Global API Drug Development Service Market Research Report 2024

Publication ID:

PB506243274

Publication Date:

June 20, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The global API Drug Development Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for API Drug Development Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for API Drug Development Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for API Drug Development Service in Small Biotechs Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of API Drug Development Service include Lonza, Patheon, Catalent, Carbogen Amcis, Sterling Pharma Solutions, Cambrex, CordenPharma, Eurofins Scientific, Malvern Panalytical, Almac, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for API Drug Development Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding API Drug Development Service.
The API Drug Development Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global API Drug Development Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the API Drug Development Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
Patheon
Catalent
Carbogen Amcis
Sterling Pharma Solutions
Cambrex
CordenPharma
Eurofins Scientific
Malvern Panalytical
Almac
Pfizer
Axplora
Aptuit
Porton
Pharmaron Beijing
Shanghai Haoyuan Chemexpress
Stapharma
Segment by Type
Captive Product Development Service
Commercial Product Development Service
Segment by Application
Small Biotechs Companies
Large Pharmaceutical Organizations
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of API Drug Development Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global API Drug Development Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Captive Product Development Service
1.2.3 Commercial Product Development Service
1.3 Market by Application
1.3.1 Global API Drug Development Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Small Biotechs Companies
1.3.3 Large Pharmaceutical Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global API Drug Development Service Market Perspective (2019-2030)
2.2 Global API Drug Development Service Growth Trends by Region
2.2.1 Global API Drug Development Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 API Drug Development Service Historic Market Size by Region (2019-2024)
2.2.3 API Drug Development Service Forecasted Market Size by Region (2025-2030)
2.3 API Drug Development Service Market Dynamics
2.3.1 API Drug Development Service Industry Trends
2.3.2 API Drug Development Service Market Drivers
2.3.3 API Drug Development Service Market Challenges
2.3.4 API Drug Development Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top API Drug Development Service Players by Revenue
3.1.1 Global Top API Drug Development Service Players by Revenue (2019-2024)
3.1.2 Global API Drug Development Service Revenue Market Share by Players (2019-2024)
3.2 Global API Drug Development Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by API Drug Development Service Revenue
3.4 Global API Drug Development Service Market Concentration Ratio
3.4.1 Global API Drug Development Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by API Drug Development Service Revenue in 2023
3.5 Global Key Players of API Drug Development Service Head office and Area Served
3.6 Global Key Players of API Drug Development Service, Product and Application
3.7 Global Key Players of API Drug Development Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 API Drug Development Service Breakdown Data by Type
4.1 Global API Drug Development Service Historic Market Size by Type (2019-2024)
4.2 Global API Drug Development Service Forecasted Market Size by Type (2025-2030)
5 API Drug Development Service Breakdown Data by Application
5.1 Global API Drug Development Service Historic Market Size by Application (2019-2024)
5.2 Global API Drug Development Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America API Drug Development Service Market Size (2019-2030)
6.2 North America API Drug Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America API Drug Development Service Market Size by Country (2019-2024)
6.4 North America API Drug Development Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe API Drug Development Service Market Size (2019-2030)
7.2 Europe API Drug Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe API Drug Development Service Market Size by Country (2019-2024)
7.4 Europe API Drug Development Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific API Drug Development Service Market Size (2019-2030)
8.2 Asia-Pacific API Drug Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific API Drug Development Service Market Size by Region (2019-2024)
8.4 Asia-Pacific API Drug Development Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America API Drug Development Service Market Size (2019-2030)
9.2 Latin America API Drug Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America API Drug Development Service Market Size by Country (2019-2024)
9.4 Latin America API Drug Development Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa API Drug Development Service Market Size (2019-2030)
10.2 Middle East & Africa API Drug Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa API Drug Development Service Market Size by Country (2019-2024)
10.4 Middle East & Africa API Drug Development Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza API Drug Development Service Introduction
11.1.4 Lonza Revenue in API Drug Development Service Business (2019-2024)
11.1.5 Lonza Recent Development
11.2 Patheon
11.2.1 Patheon Company Details
11.2.2 Patheon Business Overview
11.2.3 Patheon API Drug Development Service Introduction
11.2.4 Patheon Revenue in API Drug Development Service Business (2019-2024)
11.2.5 Patheon Recent Development
11.3 Catalent
11.3.1 Catalent Company Details
11.3.2 Catalent Business Overview
11.3.3 Catalent API Drug Development Service Introduction
11.3.4 Catalent Revenue in API Drug Development Service Business (2019-2024)
11.3.5 Catalent Recent Development
11.4 Carbogen Amcis
11.4.1 Carbogen Amcis Company Details
11.4.2 Carbogen Amcis Business Overview
11.4.3 Carbogen Amcis API Drug Development Service Introduction
11.4.4 Carbogen Amcis Revenue in API Drug Development Service Business (2019-2024)
11.4.5 Carbogen Amcis Recent Development
11.5 Sterling Pharma Solutions
11.5.1 Sterling Pharma Solutions Company Details
11.5.2 Sterling Pharma Solutions Business Overview
11.5.3 Sterling Pharma Solutions API Drug Development Service Introduction
11.5.4 Sterling Pharma Solutions Revenue in API Drug Development Service Business (2019-2024)
11.5.5 Sterling Pharma Solutions Recent Development
11.6 Cambrex
11.6.1 Cambrex Company Details
11.6.2 Cambrex Business Overview
11.6.3 Cambrex API Drug Development Service Introduction
11.6.4 Cambrex Revenue in API Drug Development Service Business (2019-2024)
11.6.5 Cambrex Recent Development
11.7 CordenPharma
11.7.1 CordenPharma Company Details
11.7.2 CordenPharma Business Overview
11.7.3 CordenPharma API Drug Development Service Introduction
11.7.4 CordenPharma Revenue in API Drug Development Service Business (2019-2024)
11.7.5 CordenPharma Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Details
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific API Drug Development Service Introduction
11.8.4 Eurofins Scientific Revenue in API Drug Development Service Business (2019-2024)
11.8.5 Eurofins Scientific Recent Development
11.9 Malvern Panalytical
11.9.1 Malvern Panalytical Company Details
11.9.2 Malvern Panalytical Business Overview
11.9.3 Malvern Panalytical API Drug Development Service Introduction
11.9.4 Malvern Panalytical Revenue in API Drug Development Service Business (2019-2024)
11.9.5 Malvern Panalytical Recent Development
11.10 Almac
11.10.1 Almac Company Details
11.10.2 Almac Business Overview
11.10.3 Almac API Drug Development Service Introduction
11.10.4 Almac Revenue in API Drug Development Service Business (2019-2024)
11.10.5 Almac Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer API Drug Development Service Introduction
11.11.4 Pfizer Revenue in API Drug Development Service Business (2019-2024)
11.11.5 Pfizer Recent Development
11.12 Axplora
11.12.1 Axplora Company Details
11.12.2 Axplora Business Overview
11.12.3 Axplora API Drug Development Service Introduction
11.12.4 Axplora Revenue in API Drug Development Service Business (2019-2024)
11.12.5 Axplora Recent Development
11.13 Aptuit
11.13.1 Aptuit Company Details
11.13.2 Aptuit Business Overview
11.13.3 Aptuit API Drug Development Service Introduction
11.13.4 Aptuit Revenue in API Drug Development Service Business (2019-2024)
11.13.5 Aptuit Recent Development
11.14 Porton
11.14.1 Porton Company Details
11.14.2 Porton Business Overview
11.14.3 Porton API Drug Development Service Introduction
11.14.4 Porton Revenue in API Drug Development Service Business (2019-2024)
11.14.5 Porton Recent Development
11.15 Pharmaron Beijing
11.15.1 Pharmaron Beijing Company Details
11.15.2 Pharmaron Beijing Business Overview
11.15.3 Pharmaron Beijing API Drug Development Service Introduction
11.15.4 Pharmaron Beijing Revenue in API Drug Development Service Business (2019-2024)
11.15.5 Pharmaron Beijing Recent Development
11.16 Shanghai Haoyuan Chemexpress
11.16.1 Shanghai Haoyuan Chemexpress Company Details
11.16.2 Shanghai Haoyuan Chemexpress Business Overview
11.16.3 Shanghai Haoyuan Chemexpress API Drug Development Service Introduction
11.16.4 Shanghai Haoyuan Chemexpress Revenue in API Drug Development Service Business (2019-2024)
11.16.5 Shanghai Haoyuan Chemexpress Recent Development
11.17 Stapharma
11.17.1 Stapharma Company Details
11.17.2 Stapharma Business Overview
11.17.3 Stapharma API Drug Development Service Introduction
11.17.4 Stapharma Revenue in API Drug Development Service Business (2019-2024)
11.17.5 Stapharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Lonza
Patheon
Catalent
Carbogen Amcis
Sterling Pharma Solutions
Cambrex
CordenPharma
Eurofins Scientific
Malvern Panalytical
Almac
Pfizer
Axplora
Aptuit
Porton
Pharmaron Beijing
Shanghai Haoyuan Chemexpress
Stapharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂